Detalles de la búsqueda
1.
Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study.
Am J Hematol
; 98(4): 645-657, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36606708
2.
Reduced frequency of cytotoxic CD56dim CD16+ NK cells leads to impaired antibody-dependent degranulation in EBV-positive classical Hodgkin lymphoma.
Cancer Immunol Immunother
; 71(1): 13-24, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33993319
3.
Attenuated cytarabine, etoposide, dexamethasone plus rituximab (R-Mini-CYVE) regimen for patients with relapsed or refractory B-cell non-Hodgkin's lymphoma not eligible for intensive chemotherapy.
Eur J Haematol
; 106(4): 574-583, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33512026
4.
High-dose cyclophosphamide for hard-to-treat patients with relapsed or refractory B-cell non-Hodgkin's lymphoma, a phase II result.
Eur J Haematol
; 104(4): 281-290, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31838764
5.
Outcomes and prognostic factors for relapsed or refractory lymphoma patients in phase I clinical trials.
Invest New Drugs
; 36(1): 62-74, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28597151
6.
Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma.
Haematologica
; 107(8): 1928-1932, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35320922
7.
Poor predictive value of positive interim FDG-PET/CT in primary mediastinal large B-cell lymphoma.
Eur J Nucl Med Mol Imaging
; 44(12): 2018-2024, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28634685
8.
Innovative therapies based on molecular orientation in patients with relapse and refractory diffuse large B-cell lymphoma: Results of LNH-EP1 study.
Am J Hematol
; 96(10): E376-E379, 2021 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34165816
9.
Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study.
Cancers (Basel)
; 15(5)2023 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36900299
10.
Outcomes of Transplant-Eligible Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Salvage Chemotherapy: The Gustave Roussy Experience.
Clin Lymphoma Myeloma Leuk
; 21(4): e373-e380, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33277224
11.
Expression of the Immune Checkpoint Regulators LAG-3 and TIM-3 in Classical Hodgkin Lymphoma.
Clin Lymphoma Myeloma Leuk
; 21(4): 257-266.e3, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33277223
12.
CD8+ T Lymphocytes Immune Depletion and LAG-3 Overexpression in Hodgkin Lymphoma Tumor Microenvironment Exposed to Anti-PD-1 Immunotherapy.
Cancers (Basel)
; 13(21)2021 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34771650
13.
Clinical significance of the loss of CD20 antigen on tumor cells in patients with relapsed or refractory follicular lymphoma.
Cancer Drug Resist
; 4(3): 710-718, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35582306
14.
Repeated courses of low-dose 2 × 2 Gy radiation therapy in patients with indolent B-cell non-Hodgkin lymphomas.
Cancer Med
; 9(11): 3725-3732, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32249547
15.
Screening a Broad Range of Solid and Haematological Tumour Types for CD70 Expression Using a Uniform IHC Methodology as Potential Patient Stratification Method.
Cancers (Basel)
; 11(10)2019 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31652572
16.
Post-shingles granulomatous dermatosis related to anti-programmed cell death 1.
Immunotherapy
; 11(7): 591-598, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30943861
17.
Kinetics and nadir of responses to immune checkpoint blockade by anti-PD1 in patients with classical Hodgkin lymphoma.
Eur J Cancer
; 91: 136-144, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29360605
18.
18F-FDG PET and CT Scans Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti-Programmed Death 1 Immune Checkpoint Inhibitor.
J Nucl Med
; 59(1): 15-24, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28596157
19.
A retrospective, matched paired analysis comparing bendamustine containing BeEAM versus BEAM conditioning regimen: results from a single center experience.
Leuk Lymphoma
; 59(11): 2580-2587, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29164977
20.
When monoclonal gammopathy-associated chronic neutrophilic leukemia is a reactive process distinct from a clonal myeloproliferative neoplasm: Lessons from mistakes.
EJHaem
; 4(3): 823-826, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37601857